Loading
PDBj
メニューPDBj@FacebookPDBj@X(formerly Twitter)PDBj@BlueSkyPDBj@YouTubewwPDB FoundationwwPDBDonate
RCSB PDBPDBeBMRBAdv. SearchSearch help

4OS1

Crystal structure of urokinase-type plasminogen activator (uPA) complexed with bicyclic peptide UK601 (bicyclic 1)

4OS1 の概要
エントリーDOI10.2210/pdb4os1/pdb
関連するPDBエントリー4GLY 4OS2 4OS4 4OS5 4OS6 4OS7
関連するBIRD辞書のPRD_IDPRD_001222
分子名称Urokinase-type plasminogen activator, bicyclic peptide UK601 (bicyclic 1), SULFATE ION, ... (5 entities in total)
機能のキーワードbicyclic peptide, inhibitor, protease, disulfide bridges, cyclization, extracellular, hydrolase-hydrolase inhibitor complex, hydrolase/hydrolase inhibitor
由来する生物種Homo sapiens (human)
細胞内の位置Secreted: P00749
タンパク質・核酸の鎖数2
化学式量合計29387.46
構造登録者
Chen, S.,Pojer, F.,Heinis, C. (登録日: 2014-02-12, 公開日: 2014-09-24, 最終更新日: 2025-03-26)
主引用文献Chen, S.,Gopalakrishnan, R.,Schaer, T.,Marger, F.,Hovius, R.,Bertrand, D.,Pojer, F.,Heinis, C.
Dithiol amino acids can structurally shape and enhance the ligand-binding properties of polypeptides.
Nat Chem, 6:1009-1016, 2014
Cited by
PubMed Abstract: The disulfide bonds that form between two cysteine residues are important in defining and rigidifying the structures of proteins and peptides. In polypeptides containing multiple cysteine residues, disulfide isomerization can lead to multiple products with different biological activities. Here, we describe the development of a dithiol amino acid (Dtaa) that can form two disulfide bridges at a single amino acid site. Application of Dtaas to a serine protease inhibitor and a nicotinic acetylcholine receptor inhibitor that contain disulfide constraints enhanced their inhibitory activities 40- and 7.6-fold, respectively. X-ray crystallographic and NMR structure analysis show that the peptide ligands containing Dtaas have retained their native tertiary structures. We furthermore show that replacement of two cysteines by Dtaas can avoid the formation of disulfide bond isomers. With these properties, Dtaas are likely to have broad application in the rational design or directed evolution of peptides and proteins with high activity and stability.
PubMed: 25343607
DOI: 10.1038/nchem.2043
主引用文献が同じPDBエントリー
実験手法
X-RAY DIFFRACTION (2.2 Å)
構造検証レポート
Validation report summary of 4os1
検証レポート(詳細版)ダウンロードをダウンロード

246905

件を2025-12-31に公開中

PDB statisticsPDBj update infoContact PDBjnumon